ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Lab4Paws Logo

Use Case

Serum from Cat with Nasal Tumor for Cancer Diagnostics & Biomarker Development

Image
image-0

Use Case

Serum from Cat with Nasal Tumor for Cancer Diagnostics & Biomarker Development

Description

The study investigated the prognostic significance of Ki-67 expression in 19 cats diagnosed with nasal adenocarcinoma and treated with hypofractionated radiotherapy (RT). The overall median survival time (MST) was 550 days, with cats showing a favorable response to treatment having significantly longer survival times (1055 days) compared to those with poor responses (369 days). Additionally, cats with high Ki-67 expression detected usin serum had longer survival times (1055 days) than those with low expression (256 days). These findings suggest that Ki-67 may serve as a potential prognostic factor for feline nasal adenocarcinoma, indicating its role in predicting treatment outcomes. [Ref: Aonta, P., Jaiyangyeun, P., Theerapan, W., Srisampan, S., Wongsali, C., Kovitvadhi, A., & Jaroensong, T. (2024). Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy. Animals, 14(24), 3573. https://doi.org/10.3390/ani14243573]

Details

Industries:

Cancer Research, Biomarker Development

Related product to Serum from Cat with Nasal Tumor for Cancer Diagnostics & Biomarker Development

Serum from Cat with Nasal Tumor for Cancer Diagnostics & Biomarker Development is a Use Case of:

Product: Feline Serum - Nasal Tumor

Product

Feline Serum - Nasal Tumor

Go to product

Your contact person

Interested in this use case? An employee of Lab4Paws is at your disposal.

Contact person image

Davide Confalonieri, PhD

CEO

More Use Cases of Lab4Paws

Get insights into the use cases of Lab4Paws

UseCase: Animal PBMCs for Antibody Discovery

Use Case

Animal PBMCs for Antibody Discovery

Antibody Production

PBMCs are used in antibody discovery due to their role in the immune response. Antibody-secreting cells (ASCs), a type of PBMC, are an excellent source of high-affinity antibodies with therapeutic potential. Millions of PBMCs can be isolated and screened to identify antigen-specific ASCs that secrete antibodies with desirable properties. One method involves microfluidic encapsulation of single ASCs into an antibody capture hydrogel, followed by antigen bait sorting using flow cytometry, enabling the rapid discovery of monoclonal antibodies. These antibodies can then be further characterized for their binding affinity and neutralizing capacity, making PBMCs a valuable resource for developing antibody-based drugs and studying immune responses. [Ref: Fischer, K., Lulla, A., So, T.Y. et al. Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02346-5]

UseCase: Beagle PBMCs for Antibody Discovery

Use Case

Beagle PBMCs for Antibody Discovery

antibody production

Beagle PBMCs have been used to generate anti-canine CD20 antibodies, which can target B cells and B cell lymphoma cells. These antibodies are tested for their binding affinity and ability to induce cell death, showing promise as therapeutic antibodies for treating canine B cell lymphoma. [Ref: Mizuno, T., Kato, Y., Kaneko, M.K. et al. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Sci Rep 10, 11476 (2020). https://doi.org/10.1038/s41598-020-68470-9]

UseCase: Pig/Minipig PBMCs for Antibody Discovery

Use Case

Pig/Minipig PBMCs for Antibody Discovery

Antibody Production

Pig PBMCs have been used in antibody discovery to isolate antigen-specific B cells for monoclonal antibody (mAb) cloning. For example, researchers have established platforms to sort antigen-specific single B cells from immunized pigs, allowing for the direct cloning and expression of antigen-specific mAbs. Sequential vaccination of pigs with different serotypes of the foot-and-mouth disease virus (FMDV) enabled the isolation of broadly neutralizing antibodies (bnAbs) by dissecting B-cell receptor (BCR) gene repertoires from PBMCs. [Ref: Li, F., Wu, S., Lv, L., Huang, S., Zhang, Z., Zerang, Z., Li, P., Cao, Y., Bao, H., Sun, P., Bai, X., He, Y., Fu, Y., Yuan, H., Ma, X., Zhao, Z., Zhang, J., Wang, J., Wang, T., Li, D., … Li, K. (2024). Discovery, recognized antigenic structures, and evolution of cross-serotype broadly neutralizing antibodies from porcine B-cell repertoires against foot-and-mouth disease virus. PLoS pathogens, 20(10), e1012623. https://doi.org/10.1371/journal.ppat.1012623]

More Products & Services of Lab4Paws.

Lab4Paws offers a wide range of products and services.

Product: Animal PBMCs

Product

Animal PBMCs

Go to product

Product: Beagle PBMCs

Product

Beagle PBMCs

Go to product

Product: Pig/Minipig PBMCs

Product

Pig/Minipig PBMCs

Go to product

Product: Cynomolgus PBMCs

Product

Cynomolgus PBMCs

Go to product

Product: Llama PBMCs

Product

Llama PBMCs

Go to product

Product: Alpaca PBMCs

Product

Alpaca PBMCs

Go to product